WeChat Mini Program
Old Version Features
Research Interests

Papers共 83 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Phase II Results of the Porcupine (PORCN) Inhibitor Zamaporvint (RXC004) in Patients with Pancreatic and Biliary Tract Cancer
J. A. Bridgewater,L. Chantrill,R. Gillmore,R. Hubner,N. Starling, F. Froeling,H. S. Wasan,B. Basu, F. Collison,B. Markman,M. Chisamore, L. Goodwin, D. Wilson, C. Phillips, J. Robertson, H. Timmis, Z. Setchellova, S. A. Woodcock,J. W. Valle
ANNALS OF ONCOLOGY (2024): S157-S157
Cited0Views0Bibtex
0
0
2632: SBRT for Hepatocellular Carcinoma: Real World Outcomes after National Commissioning in England
Douglas H. Brand, Alya Al-Siyabi, Katie Ball, Stuart Brown,Roopinder Gillmore,Daniel Krell,Aileen Marshall,Douglas MacDonald, Sophie Brown, Donna O'Sullivan, Maria Ciaponi, Thomas Richards,Glen Blackman,Tim Meyer,Maria Hawkins
Radiotherapy and Oncology (2024): S2261-S2264
Cited0Views0Bibtex
0
0
391P Phase II Results of the Porcupine (PORCN) Inhibitor Zamaporvint (RXC004) in Patients with Pancreatic and Biliary Tract Cancer
J.A. Bridgewater,L. Chantrill,R. Gillmore,R. Hubner,N. Starling, F. Froeling,H.S. Wasan,B. Basu, F. Collison,B. Markman,M. Chisamore, L. Goodwin, D. Wilson, C. Phillips, J. Robertson, H. Timmis, Z. Setchellova, S.A. Woodcock,J.W. Valle
Annals of Oncology (2024): S157
Cited0Views0Bibtex
0
0
Load More
Author Statistics

#Papers: 83

#Citation: 3920

H-Index: 23

G-Index: 53

Sociability: 7

Diversity: 3

Activity: 7

  • 合作者
  • 学生
  • 导师
No result temporarily, you can search similar Scholar with the same research interest
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn